Page last updated: 2024-09-04

satavaptan and Hyponatremia

satavaptan has been researched along with Hyponatremia in 26 studies

Research

Studies (26)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (3.85)	18.2507
2000's	9 (34.62)	29.6817
2010's	16 (61.54)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ginès, P; Guevara, M; Vilstrup, H; Watson, H	1
Kilonzo, K; Lee, JJ; Nistico, A; Yeates, K	1
Iwao, H; Izumi, Y; Miura, K	1
Kwo, PY	1
Bhandari, S; Cranston, I; Glanville, J; McCool, R; O'Reilly, K; Peri, A; Petrakova, L; Shaw, A	1
del Arbol, LR; Ginès, P; Milutinovic, S; Olteanu, D; Watson, H; Wong, F	1
Laczi, F	1
Ginès, P; Guevara, M	1
Haass, M	1
Gafter, U; Gheorghiade, M; Korzets, A; Leibovici, L; Rozen-Zvi, B; Yahav, D	1
Angeli, P; Bernardi, M; Gines, P; Gow, P; Horsmans, Y; Minini, P; Watson, H; Wong, F	1
Accordino, S; Cazzaniga, M; Salerno, F	1
Villabona, C	1
Aronson, D; Krum, H; Mueller, M; Verbalis, JG	1
Konstam, MA; Udelson, JE	1
Kettritz, R; Luft, FC	1
Coffernils, M; Couturier, B; Decaux, G; Gankam-Kengne, F; Soupart, A	1
Bleich, M; Himmerkus, N; Sievers, B	1
Dabrowska, MD; Krysiak, R; Okopień, B	1
Dahl, E; Gluud, LL; Kimer, N; Krag, A	1
Gross, P; Herbrig, K; Palm, C; Pistrosch, F	1
Ali, F; Ghali, JK; Guglin, M; Vaitkevicius, P	1
Alföldi, S; Annane, D; Decaux, G; Gross, P; Heshmati, HM; Legros, JJ; Soupart, A	1
Ghali, JK	1
Kitiyakara, C; Wilcox, CS	1
Gross, P; Palm, C	1

Reviews

16 review(s) available for satavaptan and Hyponatremia

Article	Year
Management of hyponatremia. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2014, May-13, Volume: 186, Issue:8 Topics: Antidiuretic Hormone Receptor Antagonists; Benzamides; Benzazepines; Disease Management; Female; Humans; Hyponatremia; Hypovolemia; Inappropriate ADH Syndrome; Male; Morpholines; Prognosis; Pyrroles; Receptors, Vasopressin; Risk Assessment; Severity of Illness Index; Spiro Compounds; Tolvaptan; Treatment Outcome	2014
Therapeutic potential of vasopressin-receptor antagonists in heart failure. Journal of pharmacological sciences, 2014, Volume: 124, Issue:1 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzamides; Benzazepines; Body Water; Clinical Trials as Topic; Disease Models, Animal; Heart Failure; Homeostasis; Humans; Hyponatremia; Morpholines; Pyrroles; Receptors, Vasopressin; Spiro Compounds; Tolvaptan; Ventricular Remodeling	2014
A systematic review of known interventions for the treatment of chronic nonhypovolaemic hypotonic hyponatraemia and a meta-analysis of the vaptans. Clinical endocrinology, 2017, Volume: 86, Issue:6 Topics: Antidiuretic Hormone Receptor Antagonists; Benzamides; Benzazepines; Humans; Hyponatremia; Morpholines; Osmotic Pressure; Pyrroles; Randomized Controlled Trials as Topic; Receptors, Vasopressin; Spiro Compounds; Tolvaptan	2017
[Etiology, diagnostics and therapy of hyponatremias]. Orvosi hetilap, 2008, Jul-20, Volume: 149, Issue:29 Topics: Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Blood Volume; Brain Diseases; Central Nervous System; Chronic Disease; Demeclocycline; Demyelinating Diseases; Diagnosis, Differential; Diuretics; Extracellular Fluid; Furosemide; Humans; Hyponatremia; Inappropriate ADH Syndrome; Lithium Compounds; Morpholines; Osmolar Concentration; Osmosis; Pyrroles; Severity of Illness Index; Sodium; Spiro Compounds; Time Factors; Tolvaptan; Vasopressins	2008
Hyponatremia in cirrhosis: pathogenesis, clinical significance, and management. Hepatology (Baltimore, Md.), 2008, Volume: 48, Issue:3 Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Humans; Hyponatremia; Liver Cirrhosis; Morpholines; Sodium; Spiro Compounds	2008
[Vasopressin receptor antagonists and heart failure]. Therapeutische Umschau. Revue therapeutique, 2009, Volume: 66, Issue:11 Topics: Administration, Oral; Aged; Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Controlled Clinical Trials as Topic; Female; Follow-Up Studies; Furosemide; Heart Failure; Hormone Antagonists; Humans; Hyponatremia; Indoles; Male; Morpholines; Platelet Aggregation Inhibitors; Pyrroles; Pyrrolidines; Sodium Potassium Chloride Symporter Inhibitors; Spiro Compounds; Time Factors; Tolvaptan	2009
Vasopressin receptor antagonists for the treatment of hyponatremia: systematic review and meta-analysis. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2010, Volume: 56, Issue:2 Topics: Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Humans; Hyponatremia; Morpholines; Pyrroles; Randomized Controlled Trials as Topic; Spiro Compounds; Tolvaptan; Treatment Outcome	2010
[Vasopressin receptor antagonists: the vaptans]. Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2010, Volume: 57 Suppl 2 Topics: Adult; Antidiuretic Hormone Receptor Antagonists; Aquaporin 2; Benzamides; Benzazepines; Calcium Signaling; Clinical Trials as Topic; Cyclic AMP; Double-Blind Method; Drug Therapy, Combination; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome; Kidney Tubules, Collecting; Liver Cirrhosis; Morpholines; Multicenter Studies as Topic; Neoplasms; Pituitary Gland, Anterior; Pyrroles; Randomized Controlled Trials as Topic; Receptors, Vasopressin; Second Messenger Systems; Spiro Compounds; Tolvaptan; Vasopressins	2010
[Disorders of fluid and electrolyte balance]. Deutsche medizinische Wochenschrift (1946), 2011, Volume: 136, Issue:48 Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Deamino Arginine Vasopressin; Humans; Hyperkalemia; Hypernatremia; Hyponatremia; Inappropriate ADH Syndrome; Membrane Potentials; Morpholines; Osmolar Concentration; Potassium; Randomized Controlled Trials as Topic; Sodium; Spiro Compounds; Survival Rate; Tolvaptan; Water-Electrolyte Imbalance	2011
[Hyponatremic hypervolemia in heart failure--the hot spot for vasopressin receptor antagonists?]. Wiadomosci lekarskie (Warsaw, Poland : 1960), 2012, Volume: 65, Issue:1 Topics: Antidiuretic Hormone Receptor Antagonists; Benzamides; Benzazepines; Diuretics; Heart Failure; Humans; Hyponatremia; Hypovolemia; Morpholines; Pyrroles; Spiro Compounds; Tolvaptan	2012
Meta-analysis: the safety and efficacy of vaptans (tolvaptan, satavaptan and lixivaptan) in cirrhosis with ascites or hyponatraemia. Alimentary pharmacology & therapeutics, 2012, Volume: 36, Issue:7 Topics: Antidiuretic Hormone Receptor Antagonists; Ascites; Benzamides; Benzazepines; Humans; Hyponatremia; Liver Cirrhosis; Morpholines; Pyrroles; Randomized Controlled Trials as Topic; Receptors, Vasopressin; Sodium; Spiro Compounds; Tolvaptan; Treatment Outcome	2012
Vasopressin antagonists as aquaretic agents for the treatment of hyponatremia. The American journal of medicine, 2006, Volume: 119, Issue:7 Suppl 1 Topics: Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Humans; Hyponatremia; Inappropriate ADH Syndrome; Morpholines; Pyrroles; Randomized Controlled Trials as Topic; Spiro Compounds; Tolvaptan; Vasopressins	2006
Therapeutic potential of vasopressin receptor antagonists. Drugs, 2007, Volume: 67, Issue:6 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome; Liver Cirrhosis; Morpholines; Pyrroles; Receptors, Vasopressin; Spiro Compounds; Tolvaptan	2007
Mechanisms, risks, and new treatment options for hyponatremia. Cardiology, 2008, Volume: 111, Issue:3 Topics: Antidiuretic Hormone Receptor Antagonists; Benzamides; Diuretics; Heart Failure; Hospitalization; Humans; Hyponatremia; Hypovolemia; Morpholines; Prognosis; Risk Factors; Saline Solution, Hypertonic; Spiro Compounds	2008
Vasopressin V2-receptor antagonists: panaceas for hyponatremia? Current opinion in nephrology and hypertension, 1997, Volume: 6, Issue:5 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diuretics; Humans; Hyponatremia; Morpholines; Receptors, Vasopressin; Spiro Compounds	1997
The treatment of hyponatraemia using vasopressin antagonists. Experimental physiology, 2000, Volume: 85 Spec No Topics: Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Humans; Hyponatremia; Morpholines; Pyrroles; Receptors, Vasopressin; Spiro Compounds; Vasopressins	2000

Trials

5 trial(s) available for satavaptan and Hyponatremia

Article	Year
Effects of satavaptan, a selective vasopressin V(2) receptor antagonist, on ascites and serum sodium in cirrhosis with hyponatremia: a randomized trial. Hepatology (Baltimore, Md.), 2008, Volume: 48, Issue:1 Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Ascites; Blood Circulation; Diuretics; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hyponatremia; Kidney; Liver Cirrhosis; Male; Middle Aged; Morpholines; Renin-Angiotensin System; Sodium; Spiro Compounds; Treatment Outcome	2008
Effects of a selective vasopressin V2 receptor antagonist, satavaptan, on ascites recurrence after paracentesis in patients with cirrhosis. Journal of hepatology, 2010, Volume: 53, Issue:2 Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Ascites; Combined Modality Therapy; Creatinine; Diuretics; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hyponatremia; Liver Cirrhosis; Male; Middle Aged; Morpholines; Paracentesis; Secondary Prevention; Spiro Compounds; Spironolactone; Thirst; Treatment Outcome	2010
Short- and long-term treatment of dilutional hyponatraemia with satavaptan, a selective arginine vasopressin V2-receptor antagonist: the DILIPO study. European journal of heart failure, 2011, Volume: 13, Issue:3 Topics: Adult; Aged; Antidiuretic Hormone Receptor Antagonists; Body Weight; Double-Blind Method; Female; Heart Failure; Humans; Hyponatremia; Kaplan-Meier Estimate; Male; Middle Aged; Morpholines; Sodium; Spiro Compounds; Treatment Outcome; Vasopressins; Young Adult	2011
Efficacy and tolerance of urea compared with vaptans for long-term treatment of patients with SIADH. Clinical journal of the American Society of Nephrology : CJASN, 2012, Volume: 7, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Middle Aged; Morpholines; Sodium; Spiro Compounds; Time Factors; Tolvaptan; Urea	2012
Successful long-term treatment of hyponatremia in syndrome of inappropriate antidiuretic hormone secretion with satavaptan (SR121463B), an orally active nonpeptide vasopressin V2-receptor antagonist. Clinical journal of the American Society of Nephrology : CJASN, 2006, Volume: 1, Issue:6 Topics: Administration, Oral; Adult; Aged; Antidiuretic Hormone Receptor Antagonists; Body Water; Double-Blind Method; Female; Follow-Up Studies; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Middle Aged; Morpholines; Placebos; Sodium; Spiro Compounds	2006

Other Studies

5 other study(ies) available for satavaptan and Hyponatremia

Article	Year
Improvement of hyponatremia in cirrhosis is associated with improved complex information processing. Journal of gastroenterology and hepatology, 2019, Volume: 34, Issue:11 Topics: Cognition; Humans; Hyponatremia; Liver Cirrhosis; Male; Middle Aged; Morpholines; Sodium; Spiro Compounds; Treatment Outcome	2019
Management of hyponatremia in clinical hepatology practice. Current gastroenterology reports, 2014, Volume: 16, Issue:5 Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Drinking Behavior; Fluid Therapy; Humans; Hyponatremia; Liver Cirrhosis; Morpholines; Spiro Compounds; Tolvaptan	2014
May vaptans contribute to the treatment of refractory ascites? Journal of hepatology, 2010, Volume: 53, Issue:2 Topics: Antidiuretic Hormone Receptor Antagonists; Ascites; Combined Modality Therapy; Diuretics; Dose-Response Relationship, Drug; Humans; Hyponatremia; Liver Cirrhosis; Morpholines; Paracentesis; Spiro Compounds; Spironolactone; Treatment Outcome	2010
Hyponatraemia and vasopressin in heart failure: markers or mediators? European journal of heart failure, 2011, Volume: 13, Issue:3 Topics: Antidiuretic Hormone Receptor Antagonists; Heart Failure; Humans; Hyponatremia; Morpholines; Sodium; Spiro Compounds; Vasopressins	2011
Carbamazepine affects water and electrolyte homoeostasis in rat--similarities and differences to vasopressin antagonism. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2012, Volume: 27, Issue:10 Topics: Animals; Anticonvulsants; Antidiuretic Hormone Receptor Antagonists; Carbamazepine; Dehydration; Diuresis; Female; Hyponatremia; Kidney; Morpholines; Natriuresis; Rats; Rats, Wistar; Receptors, Vasopressin; Spiro Compounds; Vasopressins; Water-Electrolyte Balance	2012